Journal article

Prediction of individual clinical outcome in MCI by means of genetic assessment and F-18-FDG PET

A Drzezga, T Grimmer, M Riemenschneider, N Lautenschlager, H Siebner, P Alexopoulus, S Minoshima, M Schwaiger, A Kurz

Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2005

Abstract

UNLABELLED: Patients with mild cognitive impairment (MCI) represent a risk population for progressing to dementia of the Alzheimer type (DAT). However, clinical criteria do not ensure reliable individual prognosis in these patients. The objective of this longitudinal, prospective study was to examine the value of (18)F-FDG PET of cerebral glucose metabolism and of genetic susceptibility, as defined by an APOEepsilon4-positive genotype, with regard to the early diagnosis of DAT in patients with MCI. METHODS: In 30 patients with the diagnosis of MCI (16 female, 14 male; age, 70 +/- 8 y), baseline and follow-up examinations (mean observation period, 16 mo) were performed. In all patients, the A..

View full abstract